{"schema_version":"1","generated_at":"2026-10-30T06:35:28.231Z","data_as_of":"2026-10-19","url":"https://www.findmykol.com/kol/sameer-parikh","json_url":"https://www.findmykol.com/kol/sameer-parikh/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"sameer-parikh","name":"Sameer Parikh","credential":"MD","title":"Associate Professor of Medicine and Consultant, Division of Hematology, Mayo Clinic Rochester","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Leukemia","therapeutic_areas":["Leukemia","Lymphoma"],"institution":"Mayo Clinic in Rochester","institution_url":"https://www.findmykol.com/institution/mayo-clinic","city":"Rochester","state":"MN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1841419348","orcid":"0000-0002-3221-7314","openalex":"A5009747339"},"summary":"Sameer Parikh is Associate Professor of Medicine and Consultant, Division of Hematology, Mayo Clinic Rochester at Mayo Clinic in Rochester. OpenAlex indexes 467 publications with 8,981 citations (h-index 47); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.","overview":{"text":"Sameer Parikh, M.D., is Associate Professor of Medicine and Consultant, Division of Hematology, Mayo Clinic Rochester at Mayo Clinic in Rochester, Minnesota. The public record shows 467 publications with 8,981 citations (h-index 47), centered on Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 11 companies, 1 NIH-funded awards (2024–2026).","bullets":["Most recent indexed publication: 2026 · Blood cancer journal","Top research focus: Chronic Lymphocytic Leukemia Research","5 registered trials on ClinicalTrials.gov","Open Payments reporting from 11 companies"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":4,"topics":3,"strength":15},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":3,"topics":1,"strength":10},{"label":"Leukemia, Lymphocytic, Chronic, B-Cell","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Leukemia, Lymphoid","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Lymphocytosis","therapeutic_area":"Hematology","trials":2,"topics":0,"strength":6},{"label":"Hodgkin Disease","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Viral Hepatitis (B/C)","therapeutic_area":"Gastroenterology","trials":1,"topics":0,"strength":3},{"label":"Hepatitis C","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"Waldenstrom Macroglobulinemia","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3}],"research_topics":["Chronic Lymphocytic Leukemia Research","Lymphoma Diagnosis and Treatment","Acute Lymphoblastic Leukemia research","CAR-T cell therapy research","Acute Myeloid Leukemia Research"],"drugs_studied":{"total":8,"shown":3,"withheld":5,"rows":[{"name":"Venclexta","generic":"Venetoclax","trials":0,"payments":19,"publications":6,"mentions":25},{"name":"Imbruvica","generic":"Ibrutinib","trials":0,"payments":7,"publications":15,"mentions":22},{"name":"Epkinly","generic":"Epcoritamab","trials":0,"payments":8,"publications":0,"mentions":8}]},"works_with":{"total":13,"shown":3,"withheld":10,"rows":[{"name":"Abbvie Inc.","trials":0,"payments":28,"mentions":28},{"name":"Merck Sharp & Dohme LLC","trials":0,"payments":11,"mentions":11},{"name":"AstraZeneca Pharmaceuticals LP","trials":0,"payments":8,"mentions":8}]}},"scholarship":{"works_count":467,"cited_by_count":8981,"h_index":47,"i10_index":130,"pubmed_count":77,"latest_activity_year":2026,"source":"works"},"trials":{"count":5,"shown":3,"withheld":2,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT06564051","title":"Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C","status":"TERMINATED","role":"Investigator","sponsor":"Mayo Clinic","source_url":"https://clinicaltrials.gov/study/NCT06564051","trial_url":"https://www.findmykol.com/trial/NCT06564051"},{"nct":"NCT04748185","title":"Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies","status":"COMPLETED","role":"Investigator","sponsor":"Mayo Clinic","source_url":"https://clinicaltrials.gov/study/NCT04748185","trial_url":"https://www.findmykol.com/trial/NCT04748185"},{"nct":"NCT04665115","title":"Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)","phase":"PHASE2","status":"WITHDRAWN","role":"Investigator","sponsor":"Academic and Community Cancer Research United","source_url":"https://clinicaltrials.gov/study/NCT04665115","trial_url":"https://www.findmykol.com/trial/NCT04665115"}],"source":"trials"},"payments":{"company_count":11,"program_years":{"first":2021,"last":2025},"rows_total":23,"shown":3,"withheld":20,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":11890,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1841419348"},{"payer":"Merck Sharp & Dohme LLC","program_year":2025,"amount_usd":9790.5,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1841419348"},{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":7585.02,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1841419348"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1841419348","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Anti-infectives","share_pct":90.7,"classes_total":3,"classes":[{"class":"SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor","setting":"administered","share_pct":54.6,"drugs":[{"name":"Remdesivir","share_pct":100}],"max_beneficiaries":12},{"class":"Human Immunoglobulin G","setting":"administered","share_pct":35.6,"drugs":[{"name":"Immune globulin","share_pct":100}],"max_beneficiaries":14}]},{"area":"Cancer & immunology","share_pct":7.2,"classes_total":2,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":5.1,"drugs":[{"name":"Imbruvica","share_pct":42.1},{"name":"Calquence","share_pct":32.1},{"name":"Brukinsa","share_pct":13.8},{"name":"Jaypirca","share_pct":11.9}],"max_beneficiaries":null},{"class":"BCL-2 Inhibitor","setting":"prescribed","share_pct":2.1,"drugs":[{"name":"Venclexta","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":1.7,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":1.7,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":20}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":96.2,"facility_pct":3.8},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2024,"last":2026},"rows_total":3,"shown":3,"withheld":0,"rows":[{"project":"R50CA291823","title":"Paradigm Shift in the Management of Patients with Previously Untreated Chronic Lymphocytic Leukemia through NCI-sponsored Clinical Trials","fiscal_year":2026,"amount_usd":124230,"organization":"MAYO CLINIC ROCHESTER","source_url":"https://reporter.nih.gov/quickSearch/R50CA291823"},{"project":"R50CA291823","title":"Paradigm Shift in the Management of Patients with Previously Untreated Chronic Lymphocytic Leukemia through NCI-sponsored Clinical Trials","fiscal_year":2025,"amount_usd":124230,"organization":"MAYO CLINIC ROCHESTER","source_url":"https://reporter.nih.gov/quickSearch/R50CA291823"},{"project":"R50CA291823","title":"Paradigm Shift in the Management of Patients with Previously Untreated Chronic Lymphocytic Leukemia through NCI-sponsored Clinical Trials","fiscal_year":2024,"amount_usd":124230,"organization":"MAYO CLINIC ROCHESTER","source_url":"https://reporter.nih.gov/quickSearch/R50CA291823"}],"source":"grants"},"congress":{"count":135,"years":{"first":2010,"last":2026},"societies":["AACR","ASCO","ASH","ESMO"],"shown":3,"withheld":132,"rows":[{"title":"Abstract 1191: Depth of immunoparesis predicts time to first therapy in newly diagnosed monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-1191","source_url":"https://doi.org/10.1158/1538-7445.am2026-1191","status":"verified"},{"title":"Abstract 4228: Validation of the CLL treatment infection model (CLL-TIM) in patients with newly diagnosed chronic lymphocytic leukemia (CLL)","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-4228","source_url":"https://doi.org/10.1158/1538-7445.am2026-4228","status":"verified"},{"title":"Abstract 5064: Ancestry-associated epigenetic differences in chronic lymphocytic leukemia","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-5064","source_url":"https://doi.org/10.1158/1538-7445.am2026-5064","status":"verified"}],"source":"congress"},"publications":{"total":77,"shown":5,"withheld":72,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia.","year":2026,"journal":"Blood cancer journal","types":["Letter"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42800804/","status":"verified"},{"title":"Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.","year":2026,"journal":"Blood","types":["Journal Article","Review","Practice Guideline"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41980020/","status":"verified"},{"title":"Artificial intelligence-enhancement of flow cytometry data accelerates the identification of measurable residual chronic lymphocytic leukemia.","year":2026,"journal":"Leukemia","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42192141/","status":"verified"},{"title":"Defining the acute BTK-loss transcriptional program in CLL using a BTK degrader.","year":2026,"journal":"Leukemia","types":["Letter"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41862595/","status":"verified"},{"title":"Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric study.","year":2026,"journal":"medRxiv : the preprint server for health sciences","types":["Journal Article","Preprint"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42238415/","status":"verified"}],"most_cited":{"total":467,"shown":5,"withheld":462,"rows":[{"title":"Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL","year":2018,"cited_by_count":962,"type":"article","source_url":"https://doi.org/10.1056/nejmoa1812836"},{"title":"Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms","year":2015,"cited_by_count":534,"type":"article","source_url":"https://doi.org/10.1158/2159-8290.cd-15-0913"},{"title":"Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL","year":2017,"cited_by_count":407,"type":"article","source_url":"https://doi.org/10.1182/blood-2017-02-765685"},{"title":"Prognostic Factors and Outcomes of Adults With Hemophagocytic Lymphohistiocytosis","year":2014,"cited_by_count":324,"type":"article","source_url":"https://doi.org/10.1016/j.mayocp.2013.12.012"},{"title":"Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia","year":2016,"cited_by_count":289,"type":"article","source_url":"https://doi.org/10.1182/blood-2016-01-689422"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Neil E. Kay","coauthored_works":303},{"name":"Timothy G. Call","coauthored_works":183},{"name":"Susan L. Slager","coauthored_works":173}],"source":"works"},"presence":{"mentions":{"total":6,"shown":3,"rows":[{"url":"https://LLS.org/award-recipient/sameer-parikh","platform":"other","status":"verified"},{"url":"https://cllsociety.org/?p=31577","platform":"other","status":"provisional"},{"url":"https://healthtree.org/cll/directory/mn/mayo-clinic-rochester-rochester-mn/sameer-parikh","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":3,"shown":3,"rows":[{"value":"M.B.B.S., University of Mumbai","source_url":"https://healthtree.org/leukemia/community/directory/mn/mayo-clinic-rochester-rochester-mn/sameer-parikh","status":"verified","collected_at":"2026-10-28"},{"value":"Board Certification in Internal Medicine","source_url":"https://healthtree.org/leukemia/community/directory/mn/mayo-clinic-rochester-rochester-mn/sameer-parikh","status":"verified","collected_at":"2026-10-28"},{"value":"Board Certification in Hematology","source_url":"https://healthtree.org/leukemia/community/directory/mn/mayo-clinic-rochester-rochester-mn/sameer-parikh","status":"verified","collected_at":"2026-10-28"}]},"roles":{"total":10,"shown":3,"rows":[{"value":"CLL Abstract Review Committee Member, American Society of Hematology Annual Meeting (2020)","source_url":"https://healthtree.org/leukemia/community/directory/mn/mayo-clinic-rochester-rochester-mn/sameer-parikh","status":"provisional","collected_at":"2026-10-28"},{"value":"CLL Abstract Coordinating Reviewer, American Society of Hematology Annual Meeting (2018)","source_url":"https://healthtree.org/leukemia/community/directory/mn/mayo-clinic-rochester-rochester-mn/sameer-parikh","status":"provisional","collected_at":"2026-10-28"},{"value":"Core Leukemia Committee Member, ECOG-ACRIN (2018)","source_url":"https://healthtree.org/leukemia/community/directory/mn/mayo-clinic-rochester-rochester-mn/sameer-parikh","status":"provisional","collected_at":"2026-10-28"}]},"awards":{"total":9,"shown":3,"rows":[{"value":"Shannon Timmins Leukemia Fellowship Award","source_url":"https://healthtree.org/leukemia/community/directory/mn/mayo-clinic-rochester-rochester-mn/sameer-parikh","status":"verified","collected_at":"2026-10-28"},{"value":"Mayo Clinic Department of Medicine Career Development Award","source_url":"https://healthtree.org/leukemia/community/directory/mn/mayo-clinic-rochester-rochester-mn/sameer-parikh","status":"verified","collected_at":"2026-10-28"},{"value":"Lymphoma SPORE Career Development Award","source_url":"https://healthtree.org/leukemia/community/directory/mn/mayo-clinic-rochester-rochester-mn/sameer-parikh","status":"verified","collected_at":"2026-10-28"}]},"secondary_affiliations":{"total":4,"shown":3,"rows":[{"value":"Internal Medicine Residency completed at St. Francis Hospital, Illinois","source_url":"https://healthtree.org/leukemia/community/directory/mn/mayo-clinic-rochester-rochester-mn/sameer-parikh","status":"verified","collected_at":"2026-10-28"},{"value":"Clinical and Research Fellowship in Leukemia, University of Texas M.D. Anderson Cancer Center","source_url":"https://healthtree.org/leukemia/community/directory/mn/mayo-clinic-rochester-rochester-mn/sameer-parikh","status":"verified","collected_at":"2026-10-28"},{"value":"Hematology and Oncology Fellowship, Mayo Clinic","source_url":"https://healthtree.org/leukemia/community/directory/mn/mayo-clinic-rochester-rochester-mn/sameer-parikh","status":"verified","collected_at":"2026-10-28"}]},"media":{"total":1,"shown":1,"rows":[{"value":"Cancer Commons article: How Would a Mayo Clinic Oncologist Manage His Own Chronic Lymphocytic Leukemia?","source_url":"https://www.cancercommons.org/authors/sameer-a-parikh-mbbsc","status":"verified","collected_at":"2026-10-28"}]}},"similar":[{"name":"Morie Gertz","slug":"morie-gertz","institution":"Mayo Clinic in Rochester","specialty":"Hematology","url":"https://www.findmykol.com/kol/morie-gertz","json_url":"https://www.findmykol.com/kol/morie-gertz/profile.json"},{"name":"Sean Pittock","slug":"sean-pittock","institution":"Mayo Clinic in Rochester","specialty":"Neurology","url":"https://www.findmykol.com/kol/sean-pittock","json_url":"https://www.findmykol.com/kol/sean-pittock/profile.json"},{"name":"Jann Sarkaria","slug":"jann-sarkaria","institution":"Mayo Clinic in Rochester","specialty":"Radiation Oncology","url":"https://www.findmykol.com/kol/jann-sarkaria","json_url":"https://www.findmykol.com/kol/jann-sarkaria/profile.json"},{"name":"Peter Noseworthy","slug":"peter-noseworthy","institution":"Mayo Clinic in Rochester","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/peter-noseworthy","json_url":"https://www.findmykol.com/kol/peter-noseworthy/profile.json"},{"name":"Hagop Kantarjian","slug":"hagop-kantarjian","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/hagop-kantarjian","json_url":"https://www.findmykol.com/kol/hagop-kantarjian/profile.json"},{"name":"Jorge Cortes","slug":"jorge-cortes","institution":"University of Alabama at Birmingham (UAB)","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/jorge-cortes","json_url":"https://www.findmykol.com/kol/jorge-cortes/profile.json"},{"name":"Ayalew Tefferi","slug":"ayalew-tefferi","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/ayalew-tefferi","json_url":"https://www.findmykol.com/kol/ayalew-tefferi/profile.json"},{"name":"Charles Sawyers","slug":"charles-sawyers","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/charles-sawyers","json_url":"https://www.findmykol.com/kol/charles-sawyers/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"payments":20,"congress":132,"publications":72,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-28"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-28"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-28"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-28"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-28"}},"methodology_url":"https://www.findmykol.com/about#methodology"}